Clinical Characterization And Outcome Of A Her2-Low Metastatic Breast Cancer (Mbc) Cohort Receiving First-Line Treatment (1l) With Et +/- Cdk 4/6 Inhibitor (Cdki)
ANNALS OF ONCOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ANNALS OF ONCOLOGY(2021)